Cancer Immunotherapy Employing an Innovative Strategy to Enhance CD4+ T Cell Help in the Tumor Microenvironment

• Liwen Song,

  Affiliations Department of Obstetrics and Gynecology, Shanghai Tenth People's Hospital of Tongji University Shanghai, China, Pharmacy School of Fudan University, Shanghai, China, Department of Pharmacology and Toxicology, Shanghai Institute of Planned Parenthood Research, Shanghai, China, Department of Pathology, Johns Hopkins Medical Institutions, Baltimore, MD, United States of America

  ⨯
• Ming-Chieh Yang,

  Affiliation General Surgery and Surgical Intensive Care, Kaohsiung Veterans General Hospital, Taiwan

  ⨯
• Jayne Knoff,

  Affiliation Department of Pathology, Johns Hopkins Medical Institutions, Baltimore, MD, United States of America

  ⨯
• T.-C. Wu,

  Affiliations Department of Pathology, Johns Hopkins Medical Institutions, Baltimore, MD, United States of America, Department of Obstetrics and Gynecology, Johns Hopkins Medical Institutions, Baltimore, MD, United States of America, Department of Molecular Microbiology and Immunology, Johns Hopkins Medical Institutions, Baltimore, MD, United States of America, Department of Oncology, Johns Hopkins Medical Institutions, Baltimore, MD, United States of America

  ⨯
• Chien-Fu Hung

  * E-mail: chung2@jhmi.edu

  Affiliations Department of Pathology, Johns Hopkins Medical Institutions, Baltimore, MD, United States of America, Department of Oncology, Johns Hopkins Medical Institutions, Baltimore, MD, United States of America

  ⨯